Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

IDEXX Laboratories, Inc. - Common Stock (NQ: IDXX )

444.53 -15.23 (-3.31%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 553,759
Open 463.63
Bid (Size) 443.94 (1)
Ask (Size) 452.00 (1)
Prev. Close 459.76
Today's Range 444.37 - 463.63
52wk Range 398.50 - 583.39
Shares Outstanding 85,075,932
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
From IDEXX Laboratories, Inc.
Via Business Wire
Why Idexx Labs Stock Rocketed Higher This Week
Via The Motley Fool

Performance

YTD
+8.73%
+8.73%
1 Month
+3.71%
+3.71%
3 Month
+5.88%
+5.88%
6 Month
-10.56%
-10.56%
1 Year
-19.98%
-19.98%

More News

Read More
Exploring the top movers within the S&P500 index during today's session.
Via Chartmill
Top S&P500 movers in Monday's session
Via Chartmill
Assessing IDEXX Laboratories: Insights From 4 Financial Analysts
Via Benzinga
(IDXX) - Analyzing IDEXX Laboratories's Short Interest
Via Benzinga
(IDXX) - Analyzing IDEXX Laboratories's Short Interest
Via Benzinga
Stocks Trim Losses On Mexico Tariff Delay, Gold Extends Records, Tesla Sinks 6%: What's Driving Markets Monday?
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
IDEXX Laboratories Posts Upbeat Results, Joins Stratasys, Saia And Other Big Stocks Moving Higher On Monday
Via Benzinga
Idexx Laboratories Barks Up A Beat, And Shares Jump To A Four-Month High
Via Investor's Business Daily
Why Is Pet Health Company IDEXX Laboratories Stock Trading Higher On Monday?
Via Benzinga
A Glimpse Into The Expert Outlook On IDEXX Laboratories Through 5 Analysts
Via Benzinga
Idexx: Q4 EPS, Revenue Beat Forecast
Via The Motley Fool
IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
From IDEXX Laboratories, Inc.
Via Business Wire
Earnings Scheduled For February 3, 2025
Via Benzinga
These S&P500 stocks have an unusual volume in today's session
Via Chartmill
Morgan Stanley Reveals Top 20 AI-Driven Stocks as Adoption Hits Critical Mass
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Jim Cramer: This Tech Stock Is A Buy, Louisiana-Pacific Has Been A 'Great Stock'
Via Benzinga
IDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results
From IDEXX Laboratories, Inc.
Via Business Wire
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Via Benzinga
SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX
From Sustainability Roundtable Inc.
Via GlobeNewswire
A Once-in-a-Decade Opportunity: 2 Magnificent S&P 500 Stocks Down 37% and 28% to Buy Before 2025
Via The Motley Fool
Topics Stocks
Exposures US Equities
IDEXX Laboratories Announces Increase in Share Repurchase Program Authorization
From IDEXX Laboratories, Inc.
Via Business Wire
IDEXX Announces CFO Transition
From IDEXX Laboratories, Inc.
Via Business Wire
Is It Time to Buy October's Worst-Performing Nasdaq Stocks?
Via The Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.